TLI
Sponsors
Washington University School of Medicine, University Health Network, Toronto
Conditions
DLBCL - Diffuse Large B Cell LymphomaLymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin
Phase 1
Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta
RecruitingNCT05950802
Start: 2023-07-14End: 2027-09-30Target: 40Updated: 2025-12-08
Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With Kymriah
WithdrawnNCT06003179
Start: 2024-04-05End: 2028-11-30Updated: 2024-11-12